DFTX
Definium Therapeutics, Inc. Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026
Definium Therapeutics is projected to report zero revenue and a consensus EPS of -$0.56 for the second quarter of 2026, with the current stock price of $43.17...
